<DOC>
	<DOC>NCT00574795</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (13vPnC) in infants of Japanese descent.</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants</brief_title>
	<detailed_description />
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2 to 6 monthold infant Available for entire study period Previous vaccination with licensed or investigational pneumococcal vaccine. Previous anaphylactic reaction to any vaccine or vaccinerelated component. Contraindication to vaccination with a pneumococcal conjugate vaccine. Bleeding diathesis or condition associated with prolonged bleeding time that would contraindicate any type of injection. Known or suspected immune deficiency or suppression.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>